e-learning
resources
Madrid 2019
Monday, 30.09.2019
The journey towards personalized medicine in asthma: where are we now?
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Chair-led expert discussion and audience Q&A
R. Buhl (Mainz, Germany) J. FitzGerald (Vancouver (BC), Canada) A. Woodcock (Manchester (Greater Manchester), United Kingdom) O. Palomares (Madrid, Spain)
Source:
International Congress 2019 – The journey towards personalized medicine in asthma: where are we now?
Session:
The journey towards personalized medicine in asthma: where are we now?
Session type:
Evening Symposium
Number:
3468
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
R. Buhl (Mainz, Germany) J. FitzGerald (Vancouver (BC), Canada) A. Woodcock (Manchester (Greater Manchester), United Kingdom) O. Palomares (Madrid, Spain). Chair-led expert discussion and audience Q&A. International Congress 2019 – The journey towards personalized medicine in asthma: where are we now?
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Diagnostic tools for Obstructive Sleep Apnoea in adults and children
Expert interview: Physiological classification of lung function impairment
Occupational exposures to respiratory diseases: A case-based discussion
Related content which might interest you:
Panel discussion and audience Q&A
Source: Annual Congress 2011 - The 2011 PAH debate: what is the biggest challenge we face to optimise patient outcome?
Year: 2011
Effectively publishing scientific work - moderated discussion
Source: Virtual Congress 2021 – How to effectively publish scientific work?
Year: 2021
Digital medical conference attendees’ reasons for attendance and ideas for conference improvement: results of an international survey
Source: Virtual Congress 2021 – Innovation in respiratory training
Year: 2021
How to write a peer review
Source: ERS Lung Science Conference 2021
Year: 2021
Involving early-career researchers in editorial work
Source: International Congress 2015 – Evolution of medical journals
Year: 2015
How to chair a poster discussion session
Source: Breathe, 15 (2) 131; 10.1183/20734735.0017-2019
Year: 2019
Practical approach with cases, interactive questions and discussion
Source: Virtual Congress 2021 – ERS Clinical practice guidelines for managing children and adolescents with bronchiectasis
Year: 2021
Practical approach with cases, interactive questions and discussion
Source: Virtual Congress 2021 – High flow nasal cannula in adults with acute respiratory failure
Year: 2021
Practical approach with cases, interactive questions and discussion
Source: Virtual Congress 2021 – ERS guidelines on non-continuous positive airway pressure therapies in obstructive sleep apnoea
Year: 2021
Practical approach with cases, interactive questions and discussion
Source: Virtual Congress 2021 – ERS clinical practice guidelines on treatment of sarcoidosis
Year: 2021
VALUE-Dx communication workshop
Source: Value-Dx event 2019: VALUE-Dx kick off meeting and course
Year: 2019
Cancer in the time of COVID-19: expert opinion on how to adapt current practice
Source: Eur Respir J, 55 (5) 2000959; 10.1183/13993003.00959-2020
Year: 2020
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept